Hutch News

New prostate cancer cell lines shed light on CRPC

New prostate cancer cell lines shed light on CRPC

From the Haffner Lab, Human Biology Division
Science SpotlightSeptember 20, 2021
Targeted therapies push metastatic prostate cancer in new directions

Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Hutch NewsNovember 14, 2017
Uncovering the path to therapy resistance in prostate tumors

Uncovering the path to therapy resistance in prostate tumors

Research explains how advanced prostate cancer becomes resistant to androgen-deprivation therapy; findings suggest androgen production occurs within metastatic prostate tumors
Hutch NewsJune 02, 2008